We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
Cap. Flow
-$37.3M
Cap. Flow %
-11.13%
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134

Top Buys

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$16M
2
STM icon
STMicroelectronics
STM
+$13.6M
3
APH icon
Amphenol
APH
+$10.9M
4
STX icon
Seagate
STX
+$7.07M
5
F icon
Ford
F
+$6.02M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$18.4M
2
LITE icon
Lumentum
LITE
+$14.5M
3
AXTI icon
AXT Inc
AXTI
+$13.3M
4
TSEM icon
Tower Semiconductor
TSEM
+$11.9M
5
MU icon
Micron Technology
MU
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 38.35%
2 Healthcare 29.66%
3 Financials 6.33%
4 Miscellaneous 6.14%
5 Consumer Discretionary 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIP icon
801
Arteris
AIP
$1.05B
$292 ﹤0.01%
+6
New +$192
CVX icon
802
Chevron
CVX
$409B
$168 ﹤0.01%
1
– –
ABR icon
803
CALL
Arbor Realty Trust
ABR
$979M
$3 ﹤0.01%
335
– –
AAPL icon
804
PUT
Apple
AAPL
$4.67T
– –
-1
Closed -$23
ABBV icon
805
AbbVie
ABBV
$453B
– –
-6,126
Closed -$1.33M
ADAG
806
Adagene
ADAG
$240M
– –
-35,126
Closed -$138K
ADPT icon
807
Adaptive Biotechnologies
ADPT
$3.87B
– –
-6,689
Closed -$92.8K
ALLY icon
808
PUT
Ally Financial
ALLY
$13.3B
– –
-94
Closed -$17.4K
AMRX icon
809
Amneal Pharmaceuticals
AMRX
$6.07B
– –
-17,808
Closed -$221K
AMTB icon
810
Amerant Bancorp
AMTB
$1.16B
– –
-20,874
Closed -$460K
ANL
811
Adlai Nortye Group ADS
ANL
$967M
– –
-33,732
Closed -$233K
ANTX icon
812
AN2 Therapeutics
ANTX
$222M
– –
-38,155
Closed -$130K
APGE icon
813
CALL
Apogee Therapeutics
APGE
– –
-566
Closed -$1.93M
APO icon
814
CALL
Apollo Global Management
APO
$78.9B
– –
-304
Closed -$75.1K
APP icon
815
PUT
Applovin
APP
$107B
– –
-1
Closed -$2.02K
ARGX icon
816
argenx
ARGX
$64.6B
– –
-253
Closed -$185K
ARKK icon
817
PUT
ARK Innovation ETF
ARKK
$6.44B
– –
-49
Closed -$2.61K
ASND icon
818
CALL
Ascendis Pharma A/S
ASND
$17.7B
– –
-237
Closed -$27.1K
AVXL icon
819
CALL
Anavex Life Sciences
AVXL
$265M
– –
-1,150
Closed -$412
AX icon
820
Axos Financial
AX
$5.56B
– –
-23,326
Closed -$1.98M
AXTI icon
821
AXT Inc
AXTI
$4.04B
– –
-233,563
Closed -$13.3M
BBT
822
Beacon Financial Corp
BBT
$2.67B
– –
-9,354
Closed -$281K
BIIB icon
823
Biogen
BIIB
$32.6B
– –
-1,903
Closed -$364K
BZ icon
824
Kanzhun
BZ
$7.56B
– –
-50,000
Closed -$670K
CAPR icon
825
Capricor Therapeutics
CAPR
$547M
– –
-19,933
Closed -$604K
31 32
33
34 35

Similar funds

JWM
Jessup Wealth Management Dayton, Ohio $335M AUM 56.2% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $335M AUM 97.32% 1-Year Est. Return
TFA
TPG Financial Advisors Portland, Oregon $335M AUM 14.14% 1-Year Est. Return
SIM
Seaview Investment Managers Miami, Florida $335M AUM 47.2% 1-Year Est. Return
OWM
OneAscent Wealth Management Birmingham, Alabama $336M AUM 20.38% 1-Year Est. Return
SS
Spinecap SAS Paris, France $335M AUM 16.94% 1-Year Est. Return
BIA
BHK Investment Advisors Birmingham, Alabama $335M AUM 20.89% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

Persistent Asset Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.

  • Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
  • Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
  • Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
  • Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
  • Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
  • Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
  • Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.